+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Transcatheter Embolization and Occlusion Devices Market Size, Share & Trends Analysis Report by Product (Coil, Non-coil),By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 210 Pages
  • April 2025
  • Region: Global
  • Grand View Research
  • ID: 4764584
The Transcatheter Embolization and Occlusion Devices Market was valued at USD 5.48 Billion in 2024, and is projected to reach USD 8.54 Billion by 2030, rising at a CAGR of 7.70%. Key drivers of the TEO devices market include increasing adoption of minimally invasive surgeries and rising prevalence of cancer.

In addition, wide usage of embolization technique as a treatment for conditions other than cancer, such as vascular malformations and fibrosis, is fueling the demand for TEO devices globally. Furthermore, introduction of technically advanced products with enhanced efficiency is supporting the global market growth. On the other hand, high cost, stringent regulatory approval procedures, and requirement of experienced healthcare professionals to perform TEO procedures are some of the factors that may have a negative impact on the market development.

Asia-Pacific TEO devices market is anticipated to witness highest CAGR, due to increasing healthcare expenditure and improving healthcare infrastructure. Rapid expansion of medical tourism industry in the emerging countries of APAC is also boosting the demand for TEO devices.

Transcatheter Embolization and Occlusion Devices Market Report Highlights

  • In 2024, The non-coil product segment dominated the market with the largest revenue share of 52.3%, propelled by its versatility and effectiveness in a wide range of clinical applications.
  • Based product, the coil segment is anticipated to grow at a significant CAGR of 7.0% over the forecast period, driven by its growing application in treating various vascular conditions.
  • North America dominated the global market with the largest revenue share of 36.6% in 2024, attributed to the increased adoption of Interventional Radiology (IR) procedures.

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Regional Scope
1.2.3. Estimates and Forecasts Timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.4.5. Details of Primary Research
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product Outlook
2.2.2. Regional Outlook
2.3. Competitive Insights
Chapter 3. Transcatheter Embolization and Occlusion Devices Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Transcatheter Embolization and Occlusion Devices Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrant
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
3.3.2.1. Political Landscape
3.3.2.2. Technological Landscape
3.3.2.3. Economic Landscape
Chapter 4. Transcatheter Embolization and Occlusion Devices Market: Product Estimates & Trend Analysis
4.1. Product Segment Dashboard
4.2. Transcatheter Embolization and Occlusion Devices Market: Product Movement Analysis
4.3. Global Transcatheter Embolization and Occlusion Devices Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Coil
4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.2. Pushable Coils
4.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.3. Detachable Coils
4.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.5. Non Coil
4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.5.2. Flow Diverting Devices
4.5.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.5.3. Embolization Particles
4.5.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.5.4. Liquid Embolics
4.5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.5.5. Other Embolization and Occlusion Devices
4.5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.5.6. Accessories
4.5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 5. Transcatheter Embolization and Occlusion Devices Market: Regional Estimates & Trend Analysis
5.1. Regional Market Dashboard
5.2. Regional Market Share Analysis, 2024 & 2030
5.3. Transcatheter Embolization and Occlusion Devices Market by Region: Key Takeaways
5.4. North America
5.4.1. U.S.
5.4.1.1. Key Country Dynamics
5.4.1.2. Regulatory Framework/ Reimbursement Structure
5.4.1.3. Competitive Scenario
5.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.2. Canada
5.4.2.1. Key Country Dynamics
5.4.2.2. Regulatory Framework/ Reimbursement Structure
5.4.2.3. Competitive Scenario
5.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.3. Mexico
5.4.3.1. Key Country Dynamics
5.4.3.2. Regulatory Framework/ Reimbursement Structure
5.4.3.3. Competitive Scenario
5.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.5. Europe
5.5.1. U.K.
5.5.1.1. Key Country Dynamics
5.5.1.2. Regulatory Framework/ Reimbursement Structure
5.5.1.3. Competitive Scenario
5.5.1.4. U.K. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.5.2. Germany
5.5.2.1. Key Country Dynamics
5.5.2.2. Regulatory Framework/ Reimbursement Structure
5.5.2.3. Competitive Scenario
5.5.2.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.5.3. France
5.5.3.1. Key Country Dynamics
5.5.3.2. Regulatory Framework/ Reimbursement Structure
5.5.3.3. Competitive Scenario
5.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.5.4. Italy
5.5.4.1. Key Country Dynamics
5.5.4.2. Regulatory Framework/ Reimbursement Structure
5.5.4.3. Competitive Scenario
5.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.5.5. Spain
5.5.5.1. Key Country Dynamics
5.5.5.2. Regulatory Framework/ Reimbursement Structure
5.5.5.3. Competitive Scenario
5.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.5.6. Denmark
5.5.6.1. Key Country Dynamics
5.5.6.2. Regulatory Framework/ Reimbursement Structure
5.5.6.3. Competitive Scenario
5.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.5.7. Sweden
5.5.7.1. Key Country Dynamics
5.5.7.2. Regulatory Framework/ Reimbursement Structure
5.5.7.3. Competitive Scenario
5.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.5.8. Norway
5.5.8.1. Key Country Dynamics
5.5.8.2. Regulatory Framework/ Reimbursement Structure
5.5.8.3. Competitive Scenario
5.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.6. Asia Pacific
5.6.1. China
5.6.1.1. Key Country Dynamics
5.6.1.2. Regulatory Framework/ Reimbursement Structure
5.6.1.3. Competitive Scenario
5.6.1.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.6.2. Japan
5.6.2.1. Key Country Dynamics
5.6.2.2. Regulatory Framework/ Reimbursement Structure
5.6.2.3. Competitive Scenario
5.6.2.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.6.3. India
5.6.3.1. Key Country Dynamics
5.6.3.2. Regulatory Framework/ Reimbursement Structure
5.6.3.3. Competitive Scenario
5.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.6.4. South Korea
5.6.4.1. Key Country Dynamics
5.6.4.2. Regulatory Framework/ Reimbursement Structure
5.6.4.3. Competitive Scenario
5.6.4.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.6.5. Australia
5.6.5.1. Key Country Dynamics
5.6.5.2. Regulatory Framework/ Reimbursement Structure
5.6.5.3. Competitive Scenario
5.6.5.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.6.6. Thailand
5.6.6.1. Key Country Dynamics
5.6.6.2. Regulatory Framework/ Reimbursement Structure
5.6.6.3. Competitive Scenario
5.6.6.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.7. Latin America
5.7.1. Latin America Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.7.2. Brazil
5.7.2.1. Key Country Dynamics
5.7.2.2. Regulatory Framework/ Reimbursement Structure
5.7.2.3. Competitive Scenario
5.7.2.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.7.3. Argentina
5.7.3.1. Key Country Dynamics
5.7.3.2. Regulatory Framework/ Reimbursement Structure
5.7.3.3. Competitive Scenario
5.7.3.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.8. Middle East and Africa
5.8.1. Middle East and Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.8.2. South Africa
5.8.2.1. Key Country Dynamics
5.8.2.2. Regulatory Framework/ Reimbursement Structure
5.8.2.3. Competitive Scenario
5.8.2.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.8.3. Saudi Arabia
5.8.3.1. Key Country Dynamics
5.8.3.2. Regulatory Framework/ Reimbursement Structure
5.8.3.3. Competitive Scenario
5.8.3.4. Saudi Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.8.4. UAE
5.8.4.1. Key Country Dynamics
5.8.4.2. Regulatory Framework/ Reimbursement Structure
5.8.4.3. Competitive Scenario
5.8.4.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.8.5. Kuwait
5.8.5.1. Key Country Dynamics
5.8.5.2. Regulatory Framework/ Reimbursement Structure
5.8.5.3. Competitive Scenario
5.8.5.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, by Key Market Participants
6.2. Company/ Competition Categorization
6.3. Vendor Landscape
6.3.1. Key Company Heat Map Analysis, 2024
6.4. Company Profiles
6.4.1. Boston Scientific Corporation
6.4.1.1. Company Overview
6.4.1.2. Financial Performance
6.4.1.3. Product Benchmarking
6.4.1.4. Strategic Initiatives
6.4.2. Terumo Corporation
6.4.2.1. Company Overview
6.4.2.2. Financial Performance
6.4.2.3. Product Benchmarking
6.4.2.4. Strategic Initiatives
6.4.3. Medtronic
6.4.3.1. Company Overview
6.4.3.2. Financial Performance
6.4.3.3. Product Benchmarking
6.4.3.4. Strategic Initiatives
6.4.4. DePuy Synthes (Johnson & Johnson)
6.4.4.1. Company Overview
6.4.4.2. Financial Performance
6.4.4.3. Product Benchmarking
6.4.4.4. Strategic Initiatives
6.4.5. Stryker
6.4.5.1. Company Overview
6.4.5.2. Financial Performance
6.4.5.3. Product Benchmarking
6.4.5.4. Strategic Initiatives
6.4.6. Cordis
6.4.6.1. Company Overview
6.4.6.2. Financial Performance
6.4.6.3. Product Benchmarking
6.4.6.4. Strategic Initiatives
6.4.7. Abbott
6.4.7.1. Company Overview
6.4.7.2. Financial Performance
6.4.7.3. Product Benchmarking
6.4.7.4. Strategic Initiatives
6.4.8. Pfizer Inc.
6.4.8.1. Company Overview
6.4.8.2. Financial Performance
6.4.8.3. Product Benchmarking
6.4.8.4. Strategic Initiatives
6.4.9. Sirtex SIR-Spheres Pty Ltd.
6.4.9.1. Company Overview
6.4.9.2. Financial Performance
6.4.9.3. Product Benchmarking
6.4.9.4. Strategic Initiatives
6.4.10. Nordion (Canada) Inc.
6.4.10.1. Company Overview
6.4.10.2. Financial Performance
6.4.10.3. Product Benchmarking
6.4.10.4. Strategic Initiatives
List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global Transcatheter Embolization and Occlusion Devices Market, By Region, 2018-2030 (USD Million)
Table 4. Global Transcatheter Embolization and Occlusion Devices Market, By Product, 2018-2030 (USD Million)
Table 5. North America Transcatheter Embolization and Occlusion Devices Market, By Country, 2018-2030 (USD Million)
Table 6. North America Transcatheter Embolization and Occlusion Devices Market, By Product, 2018-2030 (USD Million)
Table 7. U.S. Transcatheter Embolization and Occlusion Devices Market, By Product, 2018-2030 (USD Million)
Table 8. Canada Transcatheter Embolization and Occlusion Devices Market, By Product, 2018-2030 (USD Million)
Table 9. Mexico Transcatheter Embolization and Occlusion Devices Market, By Product, 2018-2030 (USD Million)
Table 10. Europe Transcatheter Embolization and Occlusion Devices Market, By Country, 2018-2030 (USD Million)
Table 11. Europe Transcatheter Embolization and Occlusion Devices Market, By Product, 2018-2030 (USD Million)
Table 12. U.K. Transcatheter Embolization and Occlusion Devices Market, By Product, 2018-2030 (USD Million)
Table 13. Germany Transcatheter Embolization and Occlusion Devices Market, By Product, 2018-2030 (USD Million)
Table 14. France Transcatheter Embolization and Occlusion Devices Market, By Product, 2018-2030 (USD Million)
Table 15. Italy Transcatheter Embolization and Occlusion Devices Market, By Product, 2018-2030 (USD Million)
Table 16. Spain Transcatheter Embolization and Occlusion Devices Market, By Product, 2018-2030 (USD Million)
Table 17. Denmark Transcatheter Embolization and Occlusion Devices Market, By Product, 2018-2030 (USD Million)
Table 18. Sweden Transcatheter Embolization and Occlusion Devices Market, By Product, 2018-2030 (USD Million)
Table 19. Norway Transcatheter Embolization and Occlusion Devices Market, By Product, 2018-2030 (USD Million)
Table 20. Asia Pacific Transcatheter Embolization and Occlusion Devices Market, By Country, 2018-2030 (USD Million)
Table 21. Asia Pacific Transcatheter Embolization and Occlusion Devices Market, By Product, 2018-2030 (USD Million)
Table 22. China Transcatheter Embolization and Occlusion Devices Market, By Product, 2018-2030 (USD Million)
Table 23. Japan Transcatheter Embolization and Occlusion Devices Market, By Product, 2018-2030 (USD Million)
Table 24. India Transcatheter Embolization and Occlusion Devices Market, By Product, 2018-2030 (USD Million)
Table 25. South Korea Transcatheter Embolization and Occlusion Devices Market, By Product, 2018-2030 (USD Million)
Table 26. Australia Transcatheter Embolization and Occlusion Devices Market, By Product, 2018-2030 (USD Million)
Table 27. Thailand Transcatheter Embolization and Occlusion Devices Market, By Product, 2018-2030 (USD Million)
Table 28. Latin America Transcatheter Embolization and Occlusion Devices Market, By Country, 2018-2030 (USD Million)
Table 29. Latin America Transcatheter Embolization and Occlusion Devices Market, By Product, 2018-2030 (USD Million)
Table 30. Brazil Transcatheter Embolization and Occlusion Devices Market, By Product, 2018-2030 (USD Million)
Table 31. Argentina Transcatheter Embolization and Occlusion Devices Market, By Product, 2018-2030 (USD Million)
Table 32. Middle East & Africa Transcatheter Embolization and Occlusion Devices Market, By Country, 2018-2030 (USD Million)
Table 33. Middle East & Africa Transcatheter Embolization and Occlusion Devices Market, By Product, 2018-2030 (USD Million)
Table 34. South Africa Transcatheter Embolization and Occlusion Devices Market, By Product, 2018-2030 (USD Million)
Table 35. Saudi Arabia Transcatheter Embolization and Occlusion Devices Market, By Product, 2018-2030 (USD Million)
Table 36. UAE Transcatheter Embolization and Occlusion Devices Market, By Product, 2018-2030 (USD Million)
Table 37. Kuwait Transcatheter Embolization and Occlusion Devices Market, By Product, 2018-2030 (USD Million)
List of Figures
Figure 1 Market Research Process
Figure 2 Data Triangulation Techniques
Figure 3 Primary Research Pattern
Figure 4 Primary Interviews
Figure 5 Market Research Approaches
Figure 6 Value-Chain-Based Sizing & Forecasting
Figure 7 QFD Modeling for Market Share Assessment
Figure 8 Market Formulation & Validation
Figure 9 Transcatheter Embolization and Occlusion Devices Market: Market Outlook
Figure 10 Transcatheter Embolization and Occlusion Devices Competitive Insights
Figure 11 Parent Market Outlook
Figure 12 Related/Ancillary Market Outlook
Figure 13 Penetration and Growth Prospect Mapping
Figure 14 Industry Value Chain Analysis
Figure 15 Transcatheter Embolization and Occlusion Devices Market Driver Impact
Figure 16 Transcatheter Embolization and Occlusion Devices Market Restraint Impact
Figure 17 Transcatheter Embolization and Occlusion Devices Market Strategic Initiatives Analysis
Figure 18 Transcatheter Embolization and Occlusion Devices Market: Product Movement Analysis
Figure 19 Transcatheter Embolization and Occlusion Devices Market: Product Outlook and Key Takeaways
Figure 20 Coil Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 21 Pushable Coils Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 22 Detachable Coils Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 23 Non Coil Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 24 Flow Diverting Devices Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 25 Embolization Particles Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 26 Liquid Embolics Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 27 Other Embolization and Occlusion Devices Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 28 Accessories Market Estimates and Forecast, 2018-2030
Figure 29 Global Transcatheter Embolization and Occlusion Devices Market: Regional Movement Analysis
Figure 30 Global Transcatheter Embolization and Occlusion Devices Market: Regional Outlook and Key Takeaways
Figure 31 North America Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 32 U.S. Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 33 Canada Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 34 Mexico Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 35 Europe Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 36 U.K. Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 37 Germany Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 38 France Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 39 Italy Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 40 Spain Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 41 Denmark Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 42 Sweden Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 43 Norway Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 44 Asia Pacific Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 45 China Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 46 Japan Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 47 India Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 48 South Korea Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 49 Australia Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 50 Thailand Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 51 Latin America Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 52 Brazil Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 53 Argentina Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 54 Middle East & Africa Market Estimates and Forecasts, 2018-2030
Figure 55 South Africa Market Estimates and Forecasts, 2018-2030
Figure 56 Saudi Arabia Market Estimates and Forecasts, 2018-2030
Figure 57 UAE Market Estimates and Forecasts, 2018-2030
Figure 58 Kuwait Market Estimates and Forecasts, 2018-2030

Companies Mentioned

The companies profiled in this Transcatheter Embolization and Occlusion Devices market report include:
  • Boston Scientific Corporation
  • Terumo Corporation
  • Medtronic
  • DePuy Synthes (Johnson & Johnson)
  • Stryker
  • Cordis
  • Abbott
  • Pfizer Inc.
  • Sirtex SIR-Spheres Pty Ltd.
  • Nordion (Canada) Inc.

Table Information